D
IARRHEA AND WEIGHT loss are prominent clinical features of thyrotoxicosis (1, 2) . Similar symptoms are observed in patients with adrenocortical insufficiency (3) . Although the metabolic clearance and production rate of the cortisol is enhanced during thyrotoxicosis (4), its net effect on adrenocortical reserves is under investigation (5) (6) (7) (8) . Currently 250 or 1 g synthetic ACTH tests are used to assess adrenocortical reserves. There have been three studies in which subnormal adrenal reserves have been reported in 20 -30% of thyrotoxic patients after iv ACTH 1-24 stimulation (5) (6) (7) (8) .
In thyrotoxicosis, serum cortisol binding globulin (CBG) levels are reduced and return to normal after induction of the euthyroid state (9, 10) . Reduction in cortisol reserves in thyrotoxic patients and its normalization after euthyroidism (5-8) could be due to variation related to CBG. In stress, like thyrotoxicosis, circulating ACTH values are expected to increase and more so in presence of adrenal insufficiency. We assessed plasma ACTH and adrenocortical response to 250 and 1 g of ACTH stimulation in patients with thyrotoxicosis before and after attainment of euthyroidism, taking into consideration changes in CBG levels, in the interpretation of cortisol response.
Subjects and Methods Subjects
Study included 49 consecutive patients with hyperthyroidism [39 females; mean Ϯ sd age, 38.0 Ϯ 12.3 yr; body mass index (BMI), 20.1 Ϯ 4.0 kg/m 2 ; median duration of symptoms, 12 months] attending endocrine clinic of the All India Institute of Medical Sciences and 50 healthy controls. Patients with thyrotoxic crisis and history of recent glucocorticoid intake were excluded. Hyperthyroidism was diagnosed based on the Volpe's criteria with Wayne's score greater than 19, serum total T 4 and TSH in the hyperthyroid range, and high 131 I uptake (11) . Forty-two patients had diffuse thyromegaly, five had multinodular goiter, and two had solitary toxic nodule on 99mTc pertechnetate thyroid scan. The healthy controls were volunteers (mean age, 35.4 Ϯ 7.6 yr; BMI, 22.8 Ϯ 3.2 kg/m 2 ) who had normal serum total T 4 and TSH. Ten milliliters of venous blood were drawn from all study subjects at 0800 h for measurement of baseline plasma ACTH, serum total cortisol, T 4 , TSH, thyroid peroxidase antibodies (TPOAb), and CBG. Intravenous ACTH (250 and 1 g; Ciba-Geigy, Basel, Switzerland) stimulation tests were performed in the initial 29 consecutive patients and 15 healthy controls. One microgram ACTH per milliliter saline was prepared afresh before each test by mixing 250 g ACTH 1-24 in 250 ml of 0.9% saline in a plastic container (12) . One and 250 g ACTH stimulation tests were performed between 0800 and 0900 h on d 1 and 2, respectively. Blood was drawn for cortisol estimation at Ϫ15, 0, ϩ30, ϩ60, and ϩ90 min after ACTH bolus. The free cortisol index (FCI) was calculated by serum cortisol/CBG (nanomoles per milligram). 
Definitions of subnormal cortisol response
The mean peak FCI during 250 and 1 g ACTH 1-24 stimulation tests in healthy controls was 12.4 Ϯ 1.4 and 9.9 Ϯ 1.04 nmol/mg, respectively. Peak FCI in 250 and 1 g ACTH 1-24 stimulation tests were considered subnormal in thyrotoxicosis if the value was less than the mean Ϫ3 sd of healthy controls (Ͻ8.2 and 6.8 nmol/mg, respectively).
Treatment
Patients were treated with carbimazole (10 -15 mg, three times a day). Serum total T 4 was measured at an interval of every 2 months. The mean duration to achieve euthyroidism was 4 Ϯ 1 months. Twenty-four patients were reassessed after clinical (BMI, 22.5 Ϯ 3.8 kg/m 2 ) and biochemical euthyroidism (mean interval 7 Ϯ 1 months), and repeat tests were performed including fasting serum CBG, plasma ACTH, and ACTH 1-24 stimulation. The Institutional Ethics Committee of All India Institute of Medical Sciences approved the study protocol, and written informed consent was obtained from all subjects.
Hormone assays
Serum and plasma samples were stored at Ϫ20 C and assays were performed together in multiple batches by electrochemiluminescence (Elecsys 2010; Roche, Mannheim, Germany). CBG and plasma ACTH were measured by RIA (Biosource Technologies, Inc., Nivelles, Belgium) and immunoradiometric kit (DiaSorin, Stillwater, MN). The normal range for plasma ACTH, 0800 h serum cortisol, total T 4 , TSH, TPOAb, and CBG were 6.0 -56.7 pg/ml, 6.2-19.4 g/dl, 5.1-14.1 g/dl, 0.3-4.2 IU/ml, less than 34.0 IU/ml, and 22-154 mg/liter, respectively. The intra-and interassay coefficients of variation for serum cortisol was 1.3-1.6%; CBG, 3.9 -5.5%; and 4.7-8.7% for TPOAb and other hormones.
Statistical analysis
SPSS software (version 11.5; SPSS, Inc., Chicago, IL) was used for statistical analyses. The data are given as mean Ϯ sd. ANOVA followed by Bonferroni post hoc test was used to compare mean of various variables in different groups. Paired t test was used to compare differences in the mean of variables before and after carbimazole therapy. Fisher's exact or 2 tests with Yates' correction were used to assess the differences in the frequency of nonparametric variables. Pearson's correlation coefficients were used for correlation analysis. The area under curve (AUC) for FCI was calculated by the trapezoidal rule. P Ͻ 0.05 was considered significant. Table 1 shows the clinical characteristics, mean plasma ACTH, serum CBG, total cortisol, and FCI at baseline and after ACTH stimulation in thyrotoxic (before and after treatment) and the control groups.
Results

Serum CBG, plasma ACTH, and FCI in thyrotoxic state
The mean serum CBG, basal plasma ACTH value (median, 32.0 pg/ml; range 11.0 -400.0 pg/ml), and frequency of supranormal plasma ACTH values were higher in thyrotoxic patients than healthy controls (Table 1) . Although the mean basal cortisol was comparable between thyrotoxic patients and the controls, the mean basal FCI was significantly higher in thyrotoxic patients. All nine thyrotoxic patients and two healthy controls with supranormal plasma ACTH had nor- Data in the same row with different superscript letters are significantly different from each other. Basal cortisol and basal FCI are the mean of 0800 h serum cortisol values on the days of 1 and 250 g ACTH stimulation. SDS, SD score. FCI ϭ cortisol/CBG. SI unit conversion factors: cortisol, 1 g/dl ϭ 27.59 nmol/liter; ACTH, 1 pg/ml ϭ 0.2202 pmol/liter.
† P values were calculated after log transformation. * and **, n is different from the whole group.
mal basal serum cortisol. Eight of nine patients with supranormal plasma ACTH had Graves' disease with TPOAb titers greater than 100 IU/ml. The mean basal FCI was comparable in thyrotoxic patients with and without supranormal plasma ACTH.
ACTH 1-24 stimulation test in patients with thyrotoxicosis and controls
ACTH 1-24 stimulation test (250 g).
The mean FCI at ϩ30, ϩ60, and ϩ90 min, peak response, and AUC for FCI was comparable in patients with thyrotoxicosis and healthy controls (Fig. 1) . Although peak cortisol response was less than 18.0 g/dl in 10 of 29 thyrotoxics, only three had subnormal peak FCI. All three subjects with subnormal peak FCI had peak cortisol values less than 18.0 g/dl. Two of these three also had supranormal ACTH.
ACTH 1-24 stimulation test (1 g).
The pattern of adrenocortical response was similar to that observed with 250 g ACTH stimulation. However, the mean FCI response including its peak and AUC were higher after 250 g ACTH in comparison with 1 g ACTH 1-24 stimulation in patient and the control groups (Table 1 and Fig. 1 ). Although 14 of 29 of thyrotoxics and three of 15 healthy controls had peak cortisol less than 18.0 g/dl, subnormal peak FCI was observed in only two thyrotoxic patients. Both these patients also had subnormal peak FCI on 250 g ACTH 1-24 stimulation.
Changes in serum CBG, plasma ACTH, and FCI after carbimazole therapy
The mean plasma ACTH and basal FCI decreased and mean serum CBG significantly increased after attainment of euthyroidism. The mean CBG, plasma ACTH, and basal FCI in thyrotoxic patients after euthyroidism were not significantly different from that in healthy controls ( Table 1) . The mean FCI response including its peak and AUC after 250 and 1 g ACTH 1-24 stimulation were comparable before and after treatment. Two of the three thyrotoxics with subnormal peak FCI on 250 g ACTH 1-24 test showed normal plasma ACTH and peak FCI response after euthyroidism. The third patient with subnormal peak FCI and elevated plasma ACTH during the euthyroid state at 6 months showed normal plasma ACTH at 10 months of follow-up.
Severity of hyperthyroidism and adrenocortical reserves
All 49 patients were stratified in two groups at a median serum total T 4 level of 22.2 g/dl. The median plasma ACTH [28.0 pg/ml, range (11-110 pg/ml) vs. 34.0 pg/ml (range 11-400 pg/ml), P ϭ 0.18], serum CBG (47.3 Ϯ 17.1 vs. 44.1 Ϯ 12.7 mg/liter, P ϭ 0.59), and basal FCI (7.4 Ϯ 3.3 vs. 8.7 Ϯ 4.0 nmol/mg, P ϭ 0.35) were comparable in the two groups. Similarly mean FCI at ϩ30, ϩ60, and ϩ90 min, peak and AUC, and the frequency of subnormal peak FCI after 250 and 1 g ACTH 1-24 stimulation were comparable in the two groups. Pearson's test showed no relationship among total T 4 , plasma ACTH, and basal and peak FCI in the thyrotoxic state.
Discussion
Holst in 1935 first reported increase in the adrenal size on autopsies of thyrotoxic patients (13) . Adrenal glands were moderately enlarged on computerized tomography in Graves' disease (7) . Although increased circulating ACTH in thyrotoxicosis is linked to skin hyperpigmentation, there are limited data on plasma ACTH levels in them. Hilton et al. (14) reported increased ACTH-like activity in thyrotoxicosis. Subsequently Yamakita et al. (8) and Gao et al. (15) reported mild elevation of plasma ACTH in Graves' disease that normalized after antithyroid drugs. In the current study, the mean plasma ACTH and FCI values were higher in patients with thyrotoxicosis than that in healthy controls and normalized after attainment of euthyroidism. Presence of adrenal enlargement and supranormal plasma ACTH coupled with significantly higher basal FCI suggest that pituitaryadrenal axis is stimulated in thyrotoxic state.
On the other hand, there are reports of subnormal peak cortisol on ACTH 1-24 stimulation tests in thyrotoxic subjects (5) (6) (7) (8) . Peak cortisol less than 18 g/dl during ACTH stimulation is considered subnormal (16) . In the current study, the peak cortisol was also less than 18.0 g/dl in 34.5 and 48.3% of thyrotoxic patients during 250 and 1 g ACTH 1-24 stimulation tests, respectively. Several investigators suggested adjustment for variation in serum CBG in interpretation of cortisol values (17) (18) (19) . Measurement of free cortisol would exclude effects related to alteration in serum CBG. Ratio of total serum cortisol and CBG, i.e. FCI, has also been shown to correlate with free cortisol levels (18) . Recently le Roux et al. (19) compared peak FCI and peak total cortisol values in 31 subjects during the perioperative period of major surgeries. Peak FCI was normal in all seven subjects in whom peak cortisol was less than 18.0 g/dl (19) . There is no study in which adrenocortical reserves have been assessed using FCI in ACTH 1-24 stimulation tests in thyrotoxic patients. The observation of the current study showing significant reduction in CBG in thyrotoxic patients and its normalization after euthyroidism is in accordance with the previous studies (9, 10) . Interestingly, majority of the patients who had peak cortisol values less than 18 g/dl on 250 and 1 g ACTH 1-24 stimulation showed normal peak FCI response. Using peak FCI less than 3 sd score of the healthy controls as the definition of subnormal peak FCI during ACTH 1-24 stimulation test, only three of 27 thyrotoxic patients (11%) had subnormal response on 250 g ACTH 1-24 stimulation. Overall, the observations of high circulating ACTH and basal FCI in thyrotoxicosis but impaired peak FCI response in 11% support adrenal hyperactivity with the possibility of adrenal exhaustion in a subset of them. Abnormalities observed in the pituitary-adrenal axis were reversible after attainment of euthyroidism. Coexistent autoimmune adrenalitis is reported in up to 5% of patients with Graves' disease (20) . Reversible nature of abnormalities in peak FCI suggests autoimmune adrenalitis as the unlikely cause of subnormal reserves.
Thus, up to 11% of thyrotoxics have subnormal peak FCI on ACTH 1-24 stimulation. Such changes occur despite high basal plasma ACTH and FCI. Use of FCI, rather than total cortisol, is required for the interpretation of cortisol values in thyrotoxicosis due to the variation in CBG. Further studies involving direct measurement of free cortisol would be helpful in assessing adrenocortical reserves in patients with thyrotoxicosis.
